Tirzepatide, a new drug expected to be approved by the FDA for weight loss in 2023, is the latest diabetes treatment to be adopted for weight loss| People.com
PEOPLE spoke with Ania Jastreboff M.D., PhD., an obesity medicine physician scientist at Yale University to better understand Wegovy and Ozempic| People.com
In a recent panel discussing obesity and weight loss drugs, Oprah Winfrey revealed she had thoughts about using Ozempic or Wegovy but believed it would be taking “the easy way out”| People.com